Compugen Target Price

Compugen (CGEN) currently reports a target price of $5. Use the charts on this page to explore Compugen's target price history and peer comparisons.

Analysts' average 12-month price target for Compugen is $5, about 100.0% upside from the current share price of $2.5. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Compugen, and consider following CGEN for alerts when major investors trade the stock.

Compugen is classified in the Healthcare sector. On target price, it currently shows $5. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CGEN with unrelated industries.